Field: Life Sciences & Biomedicine
Host: Royal Veterinary College, University of London
Funder: Orthopaedic Research UK and the Medical Research Council (MRC)
Fellowship Title: Defining the mechanism and efficacy of CDK8/19 therapies across the skeleton in pre-clinical osteoarthritis (OA) models.
Dr Burleigh is a highly qualified academic with a PhD in rheumatology and a longstanding career in MSK research with the Kennedy Institute of Rheumatology (KIR), Imperial College, London, University of Aberdeen and most recently The Royal Veterinary College (RVC).
Dr Burleigh initially took a career break to care for her premature son. This was further extended upon her diagnosis with Multiple Sclerosis, which is now stable following treatment, enabling her to resume her research career.
Her research will focus on exploring a breakthrough drug to reverse osteoarthritis (OA) damage and restore joint health.
